MEMPHIS, Tenn.--(BUSINESS WIRE)--Smith & Nephew, Inc.’s (NYSE: SNN) (LSE: SN) Orthopaedic Reconstruction business today welcomed the release of six-year clinical data that confirms the clinical superiority of Smith & Nephew, Inc.’s BIRMINGHAM HIP Resurfacing system (BHR™). The report was issued by the Australian Orthopaedic Association National Joint Replacement Registry, one of the most comprehensive registries of its kind, on 1 October 2007. Data was tracked from September 1999 to December 2006 and revealed that the BHR device has the highest hip resurfacing system survivability rate among all of its established competitors for which data had been collected, highlighting the system’s continuing exceptional clinical performance.
